Exscientia acquires personalised medicine AI pioneer Allcyte
- Deep learning platform evaluates drug activity in patient tumour microenvironments with single cell resolution
-…
WWTF-Life Sciences Call 2020: Mehr als 6 Millionen Euro für Präzisionsmedizin in Wien
Durch die Erforschung ihrer grundlegenden Mechanismen können schwere Krankheiten erkannt und künftig durch stärker…
contextflow announces mid-seven figures Series A Investment
The Austrian-based AI in radiology startup contextflow secured a mid-seven figures Series A investment led by B&C…
60 Million Euro investment for Vienna BioCenter Core Facilities
The Vienna BioCenter Core Facilities receive 60 million Euro to maintain and further develop its cutting-edge research…
Delta 4 Announces Closing of Multi-million Series A Financing Round
- Company to Expand Focus Beyond Renal Diseases and COVID-19
- Compounds Identified in Current Discovery Programs Ready…
Austrian biotech Allcyte raises $6m seed round following breakthrough cancer clinical trial
Allcyte uses automated microscopy and AI powered single-cell resolution image analysis on live patient tissue samples to…
CeMM: Solgate schließt erste Finanzierungsrunde mit IST cube und privaten Investoren
Startup von Forschern aus dem CeMM und dem IST Austria entwickelt Medikamente basierend auf Transporter-Proteinen
a:head closes another 7-digit EUR financing round
a:head bio AG today closed a second round of financing to fuel its revolutionary approach in combating neurological…
Evologic Technologies: 2,5 Millionen Euro durch neue Finanzierungsrunde
Finanzierung sichert Produktion von Biostimulantien und Biopestiziden durch neuartiges, nachhaltiges und…
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
- Expands Pipeline Beyond Ophthalmology with PP-001, a Clinical Stage, Best-in-Class DHODH Inhibitor
- PP-001 Leverages…
Wiener Biomay AG errichtet neuen Standort in aspern Seestadt
Zehnfache Biotech-Produktionskapazitäten ab 2022
HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option
HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary…